Evidence supporting the use of: Haematococcus pluvialis
For the health condition: Parkinson's Disease

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Haematococcus pluvialis is a microalga best known as a rich source of astaxanthin, a potent antioxidant carotenoid. In the context of Parkinson’s Disease (PD), there is some scientific rationale for its investigation: oxidative stress and mitochondrial dysfunction are well-established contributors to PD pathology, and astaxanthin’s antioxidant properties could theoretically provide neuroprotective benefits. Preclinical studies, mainly in vitro and in animal models, have demonstrated that astaxanthin can protect dopaminergic neurons from oxidative damage, reduce neuroinflammation, and improve mitochondrial function. For example, several rodent studies have shown that astaxanthin administration can attenuate motor deficits and neuronal loss in toxin-induced PD models.

However, direct clinical evidence for the efficacy of Haematococcus pluvialis or astaxanthin in treating or supporting PD in humans is currently lacking. No large-scale randomized controlled trials have been published as of 2024. The existing evidence base consists primarily of laboratory and animal research, which, while promising, does not provide definitive proof of benefit in humans. Thus, while there is a plausible scientific basis and some preclinical support, the evidence does not yet strongly justify its use for Parkinson’s Disease beyond experimental or adjunctive contexts.

More about Haematococcus pluvialis
More about Parkinson's Disease

Products containing Haematococcus pluvialis

We currently have no products on Vitabase that contain this ingredient.